Open access · CC-BY
via OpenAlex
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
George Cătălin Marinescu, Roua Gabriela Popescu, Gheorghe Stoian, Anca Dinischiotu
Scientific Reports · 2018 · ▲ 70 citations
Abstract
Abstract Diabetes is a chronic and progressive disease with continuously increasing prevalence, rising financial pressure on the worldwide healthcare systems. Recently, the insulin resistance, hallmark of type 2 diabetes, was cured in mice treated with NAD+ precursor β-nicotinamide mononucleotide (NMN), no toxic effects being reported. However, NMN has a high price tag, more cost effective production methods are needed. This study proposes a biotechnological NMN production method in Escherichia coli. We show that bicistronic expression of recombinant nicotinamide phosphoribosyl transferase (Nampt) and phosphoribosyl pyrophosphate (PRPP) synthetase in the presence of nicotinamide (NAM) and lactose may be a successful strategy for cost effective NMN production. Protein expression vectors carrying NAMPT gene from Haemophilus ducreyi and PRPP synthetase from Bacillus amyloliquefaciens with L135I mutation were transformed in Escherichia coli BL21(DE3)pLysS. NMN production reached a maximum of 15.42 mg per L of bacterial culture (or 17.26 mg per gram of protein) in these cells grown in PYA8 medium supplemented with 0.1% NAM and 1% lactose.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-018-30792-0
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Marinescu, G.C., Popescu, R.G., Stoian, G., & Dinischiotu, A. (2018). β-nicotinamide mononucleotide (NMN) production in Escherichia coli. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-018-30792-0
Vancouver
Marinescu GC, Popescu RG, Stoian G, Dinischiotu A. β-nicotinamide mononucleotide (NMN) production in Escherichia coli. Scientific Reports. 2018. doi:10.1038/s41598-018-30792-0.
BibTeX
@article{george2018nicoti,
title = {β-nicotinamide mononucleotide (NMN) production in Escherichia coli},
author = {George Cătălin Marinescu and Roua Gabriela Popescu and Gheorghe Stoian and Anca Dinischiotu},
journal = {Scientific Reports},
year = {2018},
doi = {10.1038/s41598-018-30792-0},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Catalysts 2023
Open access · CC-BY
Comprehensive Transformation of Escherichia coli for Nicotinamide Mononucleotide Production
Microbial Biotechnology 2021
Open access · CC-BY
Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide
Catalysts 2025
Open access · CC-BY
Novel Biosynthetic Pathway for Nicotinamide Mononucleotide Production from Cytidine in Escherichia coli
Journal of Translational Medicine 2023
Open access · CC-BY
Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis
Human Genomics 2019
Open access · CC-BY
Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease
International Journal of Molecular Sciences 2023
Open access · CC-BY